Ulceration is a common negative prognostic marker of solid tumors including melanoma. The signaling basis of ulceration is being elucidated. PHIP has been found to be amplified in wild-type melanomas, resulting in Akt activation and aerobic glycolysis (Warburg effect), associated with ulceration. The ulceration phenotype likely represents the genotype of the reactive oxygen driven tumor, in which reactive oxygen drives angiopoietin-2 production, tumor growth, and invasion. This phenotype is amenable to pharmacologic intervention. (2014) 134, 600-602. doi:10.1038/jid.2013.443 Ulceration is a common phenomenon in dermatology and an adverse prognostic factor in melanoma. For many years, ulceration has been described as ''a tumor outgrowing its blood supply''. However, if blood supply is insufficient,
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why is ulceration an adverse prognostic factor? We have shown that the majority of cutaneous ulcers are not due to insufficient vascularity, but due to excess vascularity (Arbiser et al., 2003) . High levels of matrix metalloproteinases and unstable vasculature result in a ''hostile'' environment for epithelialization, leading to ulceration (Munavalli et al., 2003) . Ultimately, the factors that promote ulceration are not well understood. Kashani-Sabet et al. have now identified pleckstrin homology domaininteracting protein (PHIP) copy number, initially as the top-rated gene differentially expressed between metastatic melanoma and primary melanoma (Bezrookove et al. 2014) . In this study, they characterized PHIP as being expressed at high levels in ulcerated melanomas. Not only was it present, the investigators also demonstrated functional consequences of PHIP overexpression. Inhibition of PHIP led to a decrease in aerobic glycolysis (Warburg effect). The Warburg effect is commonly associated with defective glucose metabolism, with glucose being metabolized to lactate instead of full metabolism through to respiration. Although the ineffective metabolism of glucose is initially counterintuitive in terms of tumor growth, more recent studies have established that tumor cells gain certain survival advantages in exchange for switching to aerobic glycolysis, namely NF-kB activation and the ability to survive under extreme hypoxia (Govindarajan et al., 2007) . The authors demonstrated the downregulation of biomarkers of the Warburg phenomenon, including LDH5, HIF1a, and VEGF.
Although this study demonstrates PHIP elegantly as a potential therapeutic target, several questions can be asked that might provide elaboration and answers about the role of PHIP in melanoma. First, is amplification the sole mechanism of increased PHIP expression? If this is the case, adjacent genes might provide advantages to melanoma, because coamplification might increase the expression of PHIP and an additional gene in a single step. Second, what are the signaling pathways downstream of PHIP amplification? Glycolysis is associated in melanoma with the reactive oxygen-driven phenotype, in which reactive oxygen drives NF-kB and angiopoietin-2 (Fried and Arbiser, 2008). Angiopoietin-2 is highly associated with ulceration, and it would be of interest to determine whether PHIP overexpression causes increased reactive oxygen generation and angiopoietin-2 expression (Lapidoth et al., 2009) . Notably, as with ulceration, angiopoietin-2 is associated with poor prognosis in solid tumors, including melanoma, lymphoid malignancies, and in sepsis (Tanaka et al., 1999; Helfrich et al., 2009; Kranidioti et al., 2009) . If this is the case, PHIP-overexpressing melanomas might be susceptible to reactive oxygen inhibition. Finally, could PHIP overexpression be a mechanism of resistance to Braf inhibition, especially as PHIP has been associated with insulin growth factor receptor 1 (IGFR1) signaling (Reuveni et al., 2013)?
So-called targeted therapies have focused on either Braf inhibition alone or combination treatment with MEK inhibitors. Predictably, resistance has arisen owing to failure to affect the phosphoinositol-3 kinase/Akt/reactive oxygen pathway. The findings of PHIP amplification in ulcerative primary melanoma should provide an impetus for targeting non-MEK/Braf pathways in melanoma, as this has been a relatively overlooked signaling pathway and one that is readily targeted (Figure 1 ). Combination or sequential targeting of MEK/ Braf inhibitors plus phosphoinositol-3 kinase/Akt/reactive oxygen pathway inhibitors could well result in improved long-term survival and even the possibility of cure.
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The author states no conflict of interest. Figure 1 . Convergence of pathways in melanoma leads to NF-jB activation and glycolysis. The major pathways in melanoma, Braf mutation, Nras mutation, and PHIP mutation all potentially involve a superoxide/Akt/NF-kB pathway (reactive oxygen-driven pathway) to result in glycolysis, NF-kB activation, and ulceration through angiopoietin-2 expression.
Clinical Implications
Ulceration is a known poor prognostic factor for melanoma.
We now are beginning to understand that ulceration is a phenotype of a specific type of signal transduction abnormality, likely that of the reactive oxygen-induced phenotype.
This phenotype can be targeted with inhibitors of superoxide production (Munson et al., 2012) , and in fact has already been used in patients with melanoma (Arbiser et al., 2012 In this issue of JID, Cristina Has and an international group of specialists on epidermolysis bullosa (EB) report on a substitution mutation of collagen XVII that is associated with several unexpected skin and mucosal features that are ordinarily not observed in patients with junctional EB other (nonHerlitz-type junctional EB) disease. The authors also find a clinical overlap with another inherited EB, the Kindler syndrome. Furthermore, the clinical features developed rather late, years and even decades after birth in most of the patients, indicating a long-lasting mechanism of functional compensation and slow progression of the inherited basement membrane (BM) damage.
Structural stability and dynamics of collagen XVII within the hemidesmosomal anchoring complex
The collagen XVII (180 kDa) was identified within the cutaneous basement membrane zone (BMZ) chronologically as the second, and functionally as the major, autoantigen of bullous pemphigoid (BP), and therefore it has also been called BPAG2 (BP antigen 2) or BP180. The final product is a trimer of three 180 kDa a1 XVII chains [a1(XVII)3], and it anchors basal keratinocytes at the hemidesmosomal plaque through the lamina lucida to the lamina densa of the BM. Its intracellular N-terminal domain contributes to hemidesmosomal plaque stability, and it interacts with the plaque proteins plectin and BPAG1 (BP230) and also with the intracellular tail of b4 integrin. The 120 kDa extracellular, flexible, collagenous ectodomain of the molecule is part of the anchoring filament and, while binding to the a6 integrin and laminin 332, crosses the lamina lucida of the BM where it anchors the lamina densa. This ectodomain contains 15 collagenous subdomains separated by 16 non-collagenous (NC) interruptions (Birk and Bruckner, 2011) . The 120 kDa ectodomain is shed from the 180 kDa transmembrane molecule at the external surface of basal keratinocytes within the NC16 domain by metalloproteinases of the ADAM (A Disintegrin And Metalloproteinase) family, predominantly by the tumor necrosis factor-converting enzyme (TACE alias ADAM 17) or by ADAM 9 or ADAM 10. The shed ecto-collagen XVII functions as a ''mobile'' component of the extracellular matrix (ECM); it is present not only in the lamina lucida but also in the uppermost dermal connective tissue. The ectodomain acquires new epitopes through proteolytic cleavage, which identify and distinguish the cleaved molecules from the uncleaved 180 kDa protein. There are also smaller shed ectodomains (e.g., 95 kDa) with distinct cleavage sites and neoepitopes. Neoepitopes within the NC16A domain are recognized preferentially in autoimmune blistering diseases such as BP, pemphigoid gestationis, and the linear IgA dermatosis (Nishie et al., 2010) .
Ectodomain shedding weakens basal keratinocyte binding to the underlying BM when the architectural stability of the molecule is disrupted. Shedding may be of physiological importance during the differentiation of the basal keratinocytes, as well as in their movement during wound healing and tissue regeneration (Hashmi and Marinkovich, 2011) .
Cross-talk along the BMZ: the key role of b-integrins in adhesome interactions
The bidirectional interaction between cells and their environment is mediated predominantly via integrins that accumulate in adhesomes. There are collagen-, laminin-, and leukocyte-binding integrins. The ability of integrins to be activated and to initiate signaling pathways depends upon the type of adhesion complexes that are formed between cells and the ECM. Activated integrins become clustered and form dynamic integrin adhesomes, which are ''signaling points' ' (Schiller and Fässler, 2013) . Proteins that bind the intracellular domain of b-integrins are able to activate these b-integrins and to increase their adhesion to the ECM. b1 integrins, the largest integrin subfamily, are usually involved in cell migration, proliferation, and differentiation, and they participate in development, tissue homeostasis, and tumor progression. Integrin-targeted biological therapies can be very effective tools for tumor suppression (Marelli et al., 2013) .
Recent studies have demonstrated how in genetically engineered cells diff-
